Re: Merck drug generates pre-release controversy

[Guest guest]

It was nauseating to watch the constant media coverage of this story

yesterday. I saw the story run on various news channels throughout

the day.

In the morning, the shot was being recommended for 11- 13 year olds.

Near days end, it was reportedly recommended for 8-9 year olds.

By the end of the week, it'll be on the AAP's list of recommended

vaccines for newborns.

Watch!

>

> Merck drug generates pre-release controversy

> By SHAWN RHEA

> Courier-Post Staff

>

>

>

> While some physicians hail Merck and Co.'s Gardasil, a vaccine

that could prevent up to 70 percent of cervical cancer cases by

blocking strains of the sexually transmitted human papillomavirus,

others admit concern over a recommendation that the three-shot

series be given to preteen, nonsexually active girls.

> " Some parents already have concerns about the safety of

vaccines in general, so asking them to vaccinate their daughters

against an STD when they aren't even sexually active is

controversial, " said Dr. Rottman, an obstetrician-gynecologist

at UMDNJ's School of Osteopathic Medicine in Stratford.

> Though Merck's 10-year study of 27,000 clinical trial patients

found Gardasil provided 100 percent protection against cervical

cancer-causing strains of HPV in properly vaccinated patients, the

trial didn't determine how long the inoculation lasts or whether

booster shots would be needed to continue protection. In addition,

the vaccine was tested only in women 16 to 26 years old.

> A Food and Drug Administration advisory committee endorsed

Gardasil on Thursday. In a unanimous vote the 13-member committee

recommended the FDA approve use of the vaccine in 11- and 12-year-

old girls, who typically have more responsive immune systems.

> " The questions that politicians and health care providers will

be batting around now is who gets it, when do they get it and

should we be screening for HPV before giving the vaccine, " said

Rottman.

> Physicians like Dr. s, an OB-GYN and medical

director of Planned Parenthood of Southern New Jersey's Camden

clinic, said parents of young girls should give serious

consideration to the vaccine's potential to save lives.

> " There are more than 10,000 cases of cervical cancer each year

in the U.S., and close to 4,000 die, " he explained. " True, we don't

know the long-term effects, but if we can trust the FDA trials,

(the vaccine) seems to have little side effects. "

> But while OB-GYNs typically address sexual activity issues

among young women, it will most likely be pediatricians and family

doctors who will be administering the HPV vaccine should it be

approved. An FDA decision is expected June 8.

> While some physicians expressed trepidation over recommending

the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes

its availability could be beneficial.

> " It's a difficult situation for parents to think of their

children involved in sexual activity and take precautions to

prevent (a future) STD, " Kaari admitted. " But what parents have to

look at is that the age of children becoming sexually active is

becoming younger and younger. "

> Reach Rhea at (856) 486-2475 or srhea@...

> Published: May 20. 2006 3:10AM

>

> ---------------------------------

> How low will we go? Check out Messenger's low PC-to-Phone

call rates.

>

[Guest guest]

In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems.

"The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.

I would test every vial for hCG http://tinyurl.com/z6d7q http://tinyurl.com/hpyah http://tinyurl.com/fty6j http://tinyurl.com/s89wp http://tinyurl.com/7u8qr.

-----Original Message-----From: EOHarm [mailto:EOHarm ]On Behalf Of Sent: Saturday, May 20, 2006 11:20 AMeoharm Subject: Merck drug generates pre-release controversy

Merck drug generates pre-release controversy

By SHAWN RHEACourier-Post Staff

While some physicians hail Merck and Co.'s Gardasil, a vaccine that could prevent up to 70 percent of cervical cancer cases by blocking strains of the sexually transmitted human papillomavirus, others admit concern over a recommendation that the three-shot series be given to preteen, nonsexually active girls.

"Some parents already have concerns about the safety of vaccines in general, so asking them to vaccinate their daughters against an STD when they aren't even sexually active is controversial," said Dr. Rottman, an obstetrician-gynecologist at UMDNJ's School of Osteopathic Medicine in Stratford.

Though Merck's 10-year study of 27,000 clinical trial patients found Gardasil provided 100 percent protection against cervical cancer-causing strains of HPV in properly vaccinated patients, the trial didn't determine how long the inoculation lasts or whether booster shots would be needed to continue protection. In addition, the vaccine was tested only in women 16 to 26 years old.

A Food and Drug Administration advisory committee endorsed Gardasil on Thursday. In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems.

"The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.

Physicians like Dr. s, an OB-GYN and medical director of Planned Parenthood of Southern New Jersey's Camden clinic, said parents of young girls should give serious consideration to the vaccine's potential to save lives.

"There are more than 10,000 cases of cervical cancer each year in the U.S., and close to 4,000 die," he explained. "True, we don't know the long-term effects, but if we can trust the FDA trials, (the vaccine) seems to have little side effects."

But while OB-GYNs typically address sexual activity issues among young women, it will most likely be pediatricians and family doctors who will be administering the HPV vaccine should it be approved. An FDA decision is expected June 8.

While some physicians expressed trepidation over recommending the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes its availability could be beneficial.

"It's a difficult situation for parents to think of their children involved in sexual activity and take precautions to prevent (a future) STD," Kaari admitted. "But what parents have to look at is that the age of children becoming sexually active is becoming younger and younger."Reach Rhea at (856) 486-2475 or srhea@...Published: May 20. 2006 3:10AM

How low will we go? Check out Messenger’s low PC-to-Phone call rates.

[Guest guest]

Where and how did they find the preteen girls to be part of their

study? Or were they all midddle-aged men?

When will the public finally understand that Pharma plays.......

god .........very badly.

Remember before induldging in further infighting, little god Pharma

would love to bring down this Group.

It is always for the children.

>

> Merck drug generates pre-release controversy

> By SHAWN RHEA

> Courier-Post Staff

>

>

>

> While some physicians hail Merck and Co.'s Gardasil, a vaccine

that could prevent up to 70 percent of cervical cancer cases by

blocking strains of the sexually transmitted human papillomavirus,

others admit concern over a recommendation that the three-shot

series be given to preteen, nonsexually active girls.

> " Some parents already have concerns about the safety of

vaccines in general, so asking them to vaccinate their daughters

against an STD when they aren't even sexually active is

controversial, " said Dr. Rottman, an obstetrician-gynecologist

at UMDNJ's School of Osteopathic Medicine in Stratford.

> Though Merck's 10-year study of 27,000 clinical trial patients

found Gardasil provided 100 percent protection against cervical

cancer-causing strains of HPV in properly vaccinated patients, the

trial didn't determine how long the inoculation lasts or whether

booster shots would be needed to continue protection. In addition,

the vaccine was tested only in women 16 to 26 years old.

> A Food and Drug Administration advisory committee endorsed

Gardasil on Thursday. In a unanimous vote the 13-member committee

recommended the FDA approve use of the vaccine in 11- and 12-year-

old girls, who typically have more responsive immune systems.

> " The questions that politicians and health care providers will

be batting around now is who gets it, when do they get it and

should we be screening for HPV before giving the vaccine, " said

Rottman.

> Physicians like Dr. s, an OB-GYN and medical

director of Planned Parenthood of Southern New Jersey's Camden

clinic, said parents of young girls should give serious

consideration to the vaccine's potential to save lives.

> " There are more than 10,000 cases of cervical cancer each year

in the U.S., and close to 4,000 die, " he explained. " True, we don't

know the long-term effects, but if we can trust the FDA trials,

(the vaccine) seems to have little side effects. "

> But while OB-GYNs typically address sexual activity issues

among young women, it will most likely be pediatricians and family

doctors who will be administering the HPV vaccine should it be

approved. An FDA decision is expected June 8.

> While some physicians expressed trepidation over recommending

the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes

its availability could be beneficial.

> " It's a difficult situation for parents to think of their

children involved in sexual activity and take precautions to

prevent (a future) STD, " Kaari admitted. " But what parents have to

look at is that the age of children becoming sexually active is

becoming younger and younger. "

> Reach Rhea at (856) 486-2475 or srhea@...

> Published: May 20. 2006 3:10AM

>

> ---------------------------------

> How low will we go? Check out Messenger's low PC-to-Phone

call rates.

>

[Guest guest]

Key phrases that hopefully parents and concerned doctors will keep asking:

" Some parents already have concerns about the safety of vaccines in

general, so asking them to vaccinate their daughters against an STD

when they aren't even sexually active is controversial, "

" True, we don't know the long-term effects, but if we can trust the

FDA trials, (the vaccine) seems to have little side effects. "

Key word:TRUST...don't!

>

> Merck drug generates pre-release controversy

> By SHAWN RHEA

> Courier-Post Staff

>

>

>

> While some physicians hail Merck and Co.'s Gardasil, a vaccine

that could prevent up to 70 percent of cervical cancer cases by

blocking strains of the sexually transmitted human papillomavirus,

others admit concern over a recommendation that the three-shot series

be given to preteen, nonsexually active girls.

> " Some parents already have concerns about the safety of vaccines

in general, so asking them to vaccinate their daughters against an

STD when they aren't even sexually active is controversial, " said Dr.

Rottman, an obstetrician-gynecologist at UMDNJ's School of

Osteopathic Medicine in Stratford.

> Though Merck's 10-year study of 27,000 clinical trial patients

found Gardasil provided 100 percent protection against cervical

cancer-causing strains of HPV in properly vaccinated patients, the

trial didn't determine how long the inoculation lasts or whether

booster shots would be needed to continue protection. In addition, the

vaccine was tested only in women 16 to 26 years old.

> A Food and Drug Administration advisory committee endorsed

Gardasil on Thursday. In a unanimous vote the 13-member committee

recommended the FDA approve use of the vaccine in 11- and 12-year-old

girls, who typically have more responsive immune systems.

> " The questions that politicians and health care providers will

be batting around now is who gets it, when do they get it and should

we be screening for HPV before giving the vaccine, " said Rottman.

> Physicians like Dr. s, an OB-GYN and medical

director of Planned Parenthood of Southern New Jersey's Camden

clinic, said parents of young girls should give serious consideration

to the vaccine's potential to save lives.

> " There are more than 10,000 cases of cervical cancer each year

in the U.S., and close to 4,000 die, " he explained. " True, we don't

know the long-term effects, but if we can trust the FDA trials, (the

vaccine) seems to have little side effects. "

> But while OB-GYNs typically address sexual activity issues among

young women, it will most likely be pediatricians and family doctors

who will be administering the HPV vaccine should it be approved. An

FDA decision is expected June 8.

> While some physicians expressed trepidation over recommending

the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes its

availability could be beneficial.

> " It's a difficult situation for parents to think of their

children involved in sexual activity and take precautions to prevent

(a future) STD, " Kaari admitted. " But what parents have to look at is

that the age of children becoming sexually active is becoming younger

and younger. "

> Reach Rhea at (856) 486-2475 or srhea@...

> Published: May 20. 2006 3:10AM

>

> ---------------------------------

> How low will we go? Check out Messenger's low PC-to-Phone

call rates.

>

[Guest guest]

Prove safety and efficacy in the 13-member panel first.

RE: Merck drug generates pre-release controversy

In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems. "The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.

I would test every vial for hCG http://tinyurl.com/z6d7q http://tinyurl.com/hpyah http://tinyurl.com/fty6j http://tinyurl.com/s89wp http://tinyurl.com/7u8qr.

-----Original Message-----From: EOHarm [mailto:EOHarm ]On Behalf Of Sent: Saturday, May 20, 2006 11:20 AMeoharm Subject: Merck drug generates pre-release controversy

Merck drug generates pre-release controversy

By SHAWN RHEACourier-Post Staff

While some physicians hail Merck and Co.'s Gardasil, a vaccine that could prevent up to 70 percent of cervical cancer cases by blocking strains of the sexually transmitted human papillomavirus, others admit concern over a recommendation that the three-shot series be given to preteen, nonsexually active girls.

"Some parents already have concerns about the safety of vaccines in general, so asking them to vaccinate their daughters against an STD when they aren't even sexually active is controversial," said Dr. Rottman, an obstetrician-gynecologist at UMDNJ's School of Osteopathic Medicine in Stratford.

Though Merck's 10-year study of 27,000 clinical trial patients found Gardasil provided 100 percent protection against cervical cancer-causing strains of HPV in properly vaccinated patients, the trial didn't determine how long the inoculation lasts or whether booster shots would be needed to continue protection. In addition, the vaccine was tested only in women 16 to 26 years old.

A Food and Drug Administration advisory committee endorsed Gardasil on Thursday. In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems.

"The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.

Physicians like Dr. s, an OB-GYN and medical director of Planned Parenthood of Southern New Jersey's Camden clinic, said parents of young girls should give serious consideration to the vaccine's potential to save lives.

"There are more than 10,000 cases of cervical cancer each year in the U.S., and close to 4,000 die," he explained. "True, we don't know the long-term effects, but if we can trust the FDA trials, (the vaccine) seems to have little side effects."

But while OB-GYNs typically address sexual activity issues among young women, it will most likely be pediatricians and family doctors who will be administering the HPV vaccine should it be approved. An FDA decision is expected June 8.

While some physicians expressed trepidation over recommending the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes its availability could be beneficial.

"It's a difficult situation for parents to think of their children involved in sexual activity and take precautions to prevent (a future) STD," Kaari admitted. "But what parents have to look at is that the age of children becoming sexually active is becoming younger and younger."Reach Rhea at (856) 486-2475 or srhea@...Published: May 20. 2006 3:10AM

How low will we go? Check out Messenger’s low PC-to-Phone call rates.

[Guest guest]

I got news for them.

This tests about as positively as the bird flu movie.

Watch the groaning and moaning begin.

Re: Merck drug generates pre-release controversy

Key phrases that hopefully parents and concerned doctors will keep asking:"Some parents already have concerns about the safety of vaccines in general, so asking them to vaccinate their daughters against an STD when they aren't even sexually active is controversial,""True, we don't know the long-term effects, but if we can trust theFDA trials, (the vaccine) seems to have little side effects."Key word:TRUST...don't!>> Merck drug generates pre-release controversy> By SHAWN RHEA> Courier-Post Staff> > > > While some physicians hail Merck and Co.'s Gardasil, a vaccinethat could prevent up to 70 percent of cervical cancer cases byblocking strains of the sexually transmitted human papillomavirus,others admit concern over a recommendation that the three-shot seriesbe given to preteen, nonsexually active girls.> "Some parents already have concerns about the safety of vaccinesin general, so asking them to vaccinate their daughters against anSTD when they aren't even sexually active is controversial," said Dr. Rottman, an obstetrician-gynecologist at UMDNJ's School ofOsteopathic Medicine in Stratford.> Though Merck's 10-year study of 27,000 clinical trial patientsfound Gardasil provided 100 percent protection against cervical cancer-causing strains of HPV in properly vaccinated patients, the trial didn't determine how long the inoculation lasts or whether booster shots would be needed to continue protection. In addition, thevaccine was tested only in women 16 to 26 years old.> A Food and Drug Administration advisory committee endorsedGardasil on Thursday. In a unanimous vote the 13-member committeerecommended the FDA approve use of the vaccine in 11- and 12-year-oldgirls, who typically have more responsive immune systems.> "The questions that politicians and health care providers willbe batting around now is who gets it, when do they get it and shouldwe be screening for HPV before giving the vaccine," said Rottman.> Physicians like Dr. s, an OB-GYN and medicaldirector of Planned Parenthood of Southern New Jersey's Camdenclinic, said parents of young girls should give serious considerationto the vaccine's potential to save lives.> "There are more than 10,000 cases of cervical cancer each yearin the U.S., and close to 4,000 die," he explained. "True, we don'tknow the long-term effects, but if we can trust the FDA trials, (thevaccine) seems to have little side effects."> But while OB-GYNs typically address sexual activity issues amongyoung women, it will most likely be pediatricians and family doctorswho will be administering the HPV vaccine should it be approved. AnFDA decision is expected June 8.> While some physicians expressed trepidation over recommendingthe vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes itsavailability could be beneficial.> "It's a difficult situation for parents to think of theirchildren involved in sexual activity and take precautions to prevent(a future) STD," Kaari admitted. "But what parents have to look at isthat the age of children becoming sexually active is becoming youngerand younger."> Reach Rhea at (856) 486-2475 or srhea@...> Published: May 20. 2006 3:10AM> > ---------------------------------> How low will we go? Check out Messenger's low PC-to-Phonecall rates.>

[Guest guest]

Anyone know if this one has thimerosal in it?

Debi

>

> Merck drug generates pre-release controversy

> By SHAWN RHEA

> Courier-Post Staff

>

>

>

> While some physicians hail Merck and Co.'s Gardasil, a vaccine

that could prevent up to 70 percent of cervical cancer cases by

blocking strains of the sexually transmitted human papillomavirus,

others admit concern over a recommendation that the three-shot series

be given to preteen, nonsexually active girls.

> " Some parents already have concerns about the safety of vaccines

in general, so asking them to vaccinate their daughters against an

STD when they aren't even sexually active is controversial, " said Dr.

Rottman, an obstetrician-gynecologist at UMDNJ's School of

Osteopathic Medicine in Stratford.

> Though Merck's 10-year study of 27,000 clinical trial patients

found Gardasil provided 100 percent protection against cervical

cancer-causing strains of HPV in properly vaccinated patients, the

trial didn't determine how long the inoculation lasts or whether

booster shots would be needed to continue protection. In addition, the

vaccine was tested only in women 16 to 26 years old.

> A Food and Drug Administration advisory committee endorsed

Gardasil on Thursday. In a unanimous vote the 13-member committee

recommended the FDA approve use of the vaccine in 11- and 12-year-old

girls, who typically have more responsive immune systems.

> " The questions that politicians and health care providers will

be batting around now is who gets it, when do they get it and should

we be screening for HPV before giving the vaccine, " said Rottman.

> Physicians like Dr. s, an OB-GYN and medical

director of Planned Parenthood of Southern New Jersey's Camden

clinic, said parents of young girls should give serious consideration

to the vaccine's potential to save lives.

> " There are more than 10,000 cases of cervical cancer each year

in the U.S., and close to 4,000 die, " he explained. " True, we don't

know the long-term effects, but if we can trust the FDA trials, (the

vaccine) seems to have little side effects. "

> But while OB-GYNs typically address sexual activity issues among

young women, it will most likely be pediatricians and family doctors

who will be administering the HPV vaccine should it be approved. An

FDA decision is expected June 8.

> While some physicians expressed trepidation over recommending

the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes its

availability could be beneficial.

> " It's a difficult situation for parents to think of their

children involved in sexual activity and take precautions to prevent

(a future) STD, " Kaari admitted. " But what parents have to look at is

that the age of children becoming sexually active is becoming younger

and younger. "

> Reach Rhea at (856) 486-2475 or srhea@...

> Published: May 20. 2006 3:10AM

>

> ---------------------------------

> How low will we go? Check out Messenger's low PC-to-Phone

call rates.

>

[Guest guest]

Frist makes things happen for the vaccinators!

Re: Merck drug generates pre-release controversy

It was nauseating to watch the constant media coverage of this story yesterday. I saw the story run on various news channels throughout the day.In the morning, the shot was being recommended for 11- 13 year olds. Near days end, it was reportedly recommended for 8-9 year olds. By the end of the week, it'll be on the AAP's list of recommended vaccines for newborns.Watch!>> Merck drug generates pre-release controversy> By SHAWN RHEA> Courier-Post Staff> > > > While some physicians hail Merck and Co.'s Gardasil, a vaccine that could prevent up to 70 percent of cervical cancer cases by blocking strains of the sexually transmitted human papillomavirus, others admit concern over a recommendation that the three-shot series be given to preteen, nonsexually active girls.> "Some parents already have concerns about the safety of vaccines in general, so asking them to vaccinate their daughters against an STD when they aren't even sexually active is controversial," said Dr. Rottman, an obstetrician-gynecologist at UMDNJ's School of Osteopathic Medicine in Stratford.> Though Merck's 10-year study of 27,000 clinical trial patients found Gardasil provided 100 percent protection against cervical cancer-causing strains of HPV in properly vaccinated patients, the trial didn't determine how long the inoculation lasts or whether booster shots would be needed to continue protection. In addition, the vaccine was tested only in women 16 to 26 years old.> A Food and Drug Administration advisory committee endorsed Gardasil on Thursday. In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems.> "The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.> Physicians like Dr. s, an OB-GYN and medical director of Planned Parenthood of Southern New Jersey's Camden clinic, said parents of young girls should give serious consideration to the vaccine's potential to save lives.> "There are more than 10,000 cases of cervical cancer each year in the U.S., and close to 4,000 die," he explained. "True, we don't know the long-term effects, but if we can trust the FDA trials, (the vaccine) seems to have little side effects."> But while OB-GYNs typically address sexual activity issues among young women, it will most likely be pediatricians and family doctors who will be administering the HPV vaccine should it be approved. An FDA decision is expected June 8.> While some physicians expressed trepidation over recommending the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes its availability could be beneficial.> "It's a difficult situation for parents to think of their children involved in sexual activity and take precautions to prevent (a future) STD," Kaari admitted. "But what parents have to look at is that the age of children becoming sexually active is becoming younger and younger."> Reach Rhea at (856) 486-2475 or srhea@...> Published: May 20. 2006 3:10AM> > ---------------------------------> How low will we go? Check out Messenger's low PC-to-Phone call rates.>

[Guest guest]

All that needs to happen is the director at HHS has to declare an epidemic. Incredulously, Leavitt has already declared bird flu an epidemic meaning that the certainly experimental vaccine will have full liability immunity. What's even more amazing is the entire Senate knew Frist added the rider to the defense conference report. They actually knew there was absolutely NO COMPENSATION plan on it and still voted to approve it.

Our old friend Lieberman beat his chest for being able to stop artic oil drilling, but he and everybody else ignored the Frist rider. His health advisor pointed out when the anthrax scare came around Bayer provided Congress with a million doses of Cipro. Since many people took the drug they've developed lots of health problems directly related to it. There are supposed to be a few million dollars worth of lawsuits pending.

Bayer took advantage of the moment and Cipro became the most famous drug on the planet as a result. You can't measure the amount of FREE advertising they got in exchange for the freebie. The question that Lieberman's health advisor couldn't answer is why should the law be any different if Cipro sterilizes people's guts on a Tuesday or during a bioterror incident?

Of course, we know that the actual anthrax scare was an inside job with the pathogens directly traced to a US Army germ warfare lab in Iowa. Hey didn't Judith release a bioterrorism book called "Germ" right before the anthrax scare? Hey wasn't that Judith that got a hoax letter during the anthrax scare? The same Judith that was spotted running around in the Iraqi desert leading an Army A-team on a wild goose chase for WMD? The same Judith that committed an act of treason by blabbing the name of a CIA operative? The same Judith that drew comparisons to the "runaway bride" Wilbanks as she sat around in jail waiting for the right person to file a release?

RERe: Merck drug generates pre-release controversy

In my conspiracy frame of mind , I imagine that all of these girls get the shot starting this fall at the same time the bird flu crosses into Alaska (CNN reports that the scientists are testing migratory birds), unlike what the article states (that girls have responsive immune systems), these girls will might actually have suppressed immune systems from the impending bird flu. Or the other scenario I see, is that these girls (like our autistic sons and daughters) may have a toxic overload from the new shot and become a new form of autism. The article here already states that they do not know the long term effects; therefore, once again, the medically establishment gets to experiment on children while they pocket the wealth. I sure would like to hear more from the doctors who have reservations about this new vaccine.

[Guest guest]

If they can battle the morning after pill, can't they do something to stop this?

RE: Merck drug generates pre-release controversy

In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems. "The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.

I would test every vial for hCG http://tinyurl.com/z6d7q http://tinyurl.com/hpyah http://tinyurl.com/fty6j http://tinyurl.com/s89wp http://tinyurl.com/7u8qr.

-----Original Message-----From: EOHarm [mailto:EOHarm ]On Behalf Of Sent: Saturday, May 20, 2006 11:20 AMeoharm Subject: Merck drug generates pre-release controversy

Merck drug generates pre-release controversy

By SHAWN RHEACourier-Post Staff

While some physicians hail Merck and Co.'s Gardasil, a vaccine that could prevent up to 70 percent of cervical cancer cases by blocking strains of the sexually transmitted human papillomavirus, others admit concern over a recommendation that the three-shot series be given to preteen, nonsexually active girls.

"Some parents already have concerns about the safety of vaccines in general, so asking them to vaccinate their daughters against an STD when they aren't even sexually active is controversial," said Dr. Rottman, an obstetrician-gynecologist at UMDNJ's School of Osteopathic Medicine in Stratford.

Though Merck's 10-year study of 27,000 clinical trial patients found Gardasil provided 100 percent protection against cervical cancer-causing strains of HPV in properly vaccinated patients, the trial didn't determine how long the inoculation lasts or whether booster shots would be needed to continue protection. In addition, the vaccine was tested only in women 16 to 26 years old.

A Food and Drug Administration advisory committee endorsed Gardasil on Thursday. In a unanimous vote the 13-member committee recommended the FDA approve use of the vaccine in 11- and 12-year-old girls, who typically have more responsive immune systems.

"The questions that politicians and health care providers will be batting around now is who gets it, when do they get it and should we be screening for HPV before giving the vaccine," said Rottman.

Physicians like Dr. s, an OB-GYN and medical director of Planned Parenthood of Southern New Jersey's Camden clinic, said parents of young girls should give serious consideration to the vaccine's potential to save lives.

"There are more than 10,000 cases of cervical cancer each year in the U.S., and close to 4,000 die," he explained. "True, we don't know the long-term effects, but if we can trust the FDA trials, (the vaccine) seems to have little side effects."

But while OB-GYNs typically address sexual activity issues among young women, it will most likely be pediatricians and family doctors who will be administering the HPV vaccine should it be approved. An FDA decision is expected June 8.

While some physicians expressed trepidation over recommending the vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes its availability could be beneficial.

"It's a difficult situation for parents to think of their children involved in sexual activity and take precautions to prevent (a future) STD," Kaari admitted. "But what parents have to look at is that the age of children becoming sexually active is becoming younger and younger."Reach Rhea at (856) 486-2475 or srhea@...Published: May 20. 2006 3:10AM

How low will we go? Check out Messenger’s low PC-to-Phone call rates.

[Guest guest]

Speaking of the bird flu. Since Congress gave them $7.1 billion dollars the CDC head said that "yeah, it's a problem if you're a bird".

Re: Merck drug generates pre-release controversy

Key phrases that hopefully parents and concerned doctors will keep asking:"Some parents already have concerns about the safety of vaccines in general, so asking them to vaccinate their daughters against an STD when they aren't even sexually active is controversial,""True, we don't know the long-term effects, but if we can trust theFDA trials, (the vaccine) seems to have little side effects."Key word:TRUST...don't!>> Merck drug generates pre-release controversy> By SHAWN RHEA> Courier-Post Staff> > > > While some physicians hail Merck and Co.'s Gardasil, a vaccinethat could prevent up to 70 percent of cervical cancer cases byblocking strains of the sexually transmitted human papillomavirus,others admit concern over a recommendation that the three-shot seriesbe given to preteen, nonsexually active girls.> "Some parents already have concerns about the safety of vaccinesin general, so asking them to vaccinate their daughters against anSTD when they aren't even sexually active is controversial," said Dr. Rottman, an obstetrician-gynecologist at UMDNJ's School ofOsteopathic Medicine in Stratford.> Though Merck's 10-year study of 27,000 clinical trial patientsfound Gardasil provided 100 percent protection against cervical cancer-causing strains of HPV in properly vaccinated patients, the trial didn't determine how long the inoculation lasts or whether booster shots would be needed to continue protection. In addition, thevaccine was tested only in women 16 to 26 years old.> A Food and Drug Administration advisory committee endorsedGardasil on Thursday. In a unanimous vote the 13-member committeerecommended the FDA approve use of the vaccine in 11- and 12-year-oldgirls, who typically have more responsive immune systems.> "The questions that politicians and health care providers willbe batting around now is who gets it, when do they get it and shouldwe be screening for HPV before giving the vaccine," said Rottman.> Physicians like Dr. s, an OB-GYN and medicaldirector of Planned Parenthood of Southern New Jersey's Camdenclinic, said parents of young girls should give serious considerationto the vaccine's potential to save lives.> "There are more than 10,000 cases of cervical cancer each yearin the U.S., and close to 4,000 die," he explained. "True, we don'tknow the long-term effects, but if we can trust the FDA trials, (thevaccine) seems to have little side effects."> But while OB-GYNs typically address sexual activity issues amongyoung women, it will most likely be pediatricians and family doctorswho will be administering the HPV vaccine should it be approved. AnFDA decision is expected June 8.> While some physicians expressed trepidation over recommendingthe vaccine, UMDNJ-SOM pediatrician Dr. Kaari believes itsavailability could be beneficial.> "It's a difficult situation for parents to think of theirchildren involved in sexual activity and take precautions to prevent(a future) STD," Kaari admitted. "But what parents have to look at isthat the age of children becoming sexually active is becoming youngerand younger."> Reach Rhea at (856) 486-2475 or srhea@...> Published: May 20. 2006 3:10AM> > ---------------------------------> How low will we go? Check out Messenger's low PC-to-Phonecall rates.>

[Guest guest]

and RUMSFELD,

former C o B of Gilead Sciences , has seen the value of his stock in that company increase in worth by more than $1,000,000 since it was granted an exclusive license to produce bird flu vaccine for our armed forces personnel/

You will really that he was responsible for glutamate, a potent carcinogen, never approved by the FDA, but instead by presidential elect./

H. H.Fudenberg, M.D.,DDG.IOM

Inman, SC 29349

(864) 592 8076

Website nitrf.org

From: "Kerbob" <robertbloch@...>Reply-EOHarm To: <EOHarm >Subject: Re: Merck drug generates pre-release controversyDate: Sat, 20 May 2006 23:04:17 -0400

All that needs to happen is the director at HHS has to declare an epidemic. Incredulously, Leavitt has already declared bird flu an epidemic meaning that the certainly experimental vaccine will have full liability immunity. What's even more amazing is the entire Senate knew Frist added the rider to the defense conference report. They actually knew there was absolutely NO COMPENSATION plan on it and still voted to approve it.

Our old friend Lieberman beat his chest for being able to stop artic oil drilling, but he and everybody else ignored the Frist rider. His health advisor pointed out when the anthrax scare came around Bayer provided Congress with a million doses of Cipro. Since many people took the drug they've developed lots of health problems directly related to it. There are supposed to be a few million dollars worth of lawsuits pending.

Bayer took advantage of the moment and Cipro became the most famous drug on the planet as a result. You can't measure the amount of FREE advertising they got in exchange for the freebie. The question that Lieberman's health advisor couldn't answer is why should the law be any different if Cipro sterilizes people's guts on a Tuesday or during a bioterror incident?

Of course, we know that the actual anthrax scare was an inside job with the pathogens directly traced to a US Army germ warfare lab in Iowa. Hey didn't Judith release a bioterrorism book called "Germ" right before the anthrax scare? Hey wasn't that Judith that got a hoax letter during the anthrax scare? The same Judith that was spotted running around in the Iraqi desert leading an Army A-team on a wild goose chase for WMD? The same Judith that committed an act of treason by blabbing the name of a CIA operative? The same Judith that drew comparisons to the "runaway bride" Wilbanks as she sat around in jail waiting for the right person to file a release?

RERe: Merck drug generates pre-release controversy

In my conspiracy frame of mind , I imagine that all of these girls get the shot starting this fall at the same time the bird flu crosses into Alaska (CNN reports that the scientists are testing migratory birds), unlike what the article states (that girls have responsive immune systems), these girls will might actually have suppressed immune systems from the impending bird flu. Or the other scenario I see, is that these girls (like our autistic sons and daughters) may have a toxic overload from the new shot and become a new form of autism. The article here already states that they do not know the long term effects; therefore, once again, the medically establishment gets to experiment on children while they pocket the wealth. I sure would like to hear more from the doctors who have reservations about this new vaccine.

[Guest guest]

> Leavitt has already declared bird flu an epidemic

There was a news report from February stating that Leavitt expected to

declare bird flu pandemic under the new law, but as far as I know he

has not officially done so yet.

Do you mean he has described it as an epidemic, so he will likely

invoke the " pandemic countermeasure " provisions of the " Public

Readiness and Emergency Preparedness Act " . If Leavitt had already done

so I thought we would have heard something about it.

Anything specific that you heard or read?

On May 20, 2006, at 11:04 PM, Kerbob wrote:

[Guest guest]

http://money.cnn.com/2005/10/31/news/newsmakers/fortune_rumsfeld/

Rumsfeld's growing stake in TamifluDefense Secretary, ex-chairman of flu treatment rights holder, sees portfolio value growing.October 31, 2005: 10:55 AM EST By D. Schwartz, Fortune senior writer

NEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world.

The worldwide call for a bird flu pandemic scare and Rumsfeld's subsequent personal gains are right in line with the White House's ideal interpretation of:

RERe: Merck drug generates pre-release controversy

In my conspiracy frame of mind , I imagine that all of these girls get the shot starting this fall at the same time the bird flu crosses into Alaska (CNN reports that the scientists are testing migratory birds), unlike what the article states (that girls have responsive immune systems), these girls will might actually have suppressed immune systems from the impending bird flu. Or the other scenario I see, is that these girls (like our autistic sons and daughters) may have a toxic overload from the new shot and become a new form of autism. The article here already states that they do not know the long term effects; therefore, once again, the medically establishment gets to experiment on children while they pocket the wealth. I sure would like to hear more from the doctors who have reservations about this new vaccine.

[Guest guest]

http://www.npr.org/templates/story/story.php?storyId=5068163

Under the law, manufacturers would receive the protection from lawsuits when the Secretary of Health and Human Services declares a particular disease as an "epidemic." Already HHS Secretary Mike Leavitt has used the word epidemic in relation to AIDS, obesity, diabetes and chronic diseases in general, potentially broadening the legal protections to many drugs now in existence or under development.

http://www.signonsandiego.com/news/health/20060213-1418-birdflu-leavitt.html

By Freking

ASSOCIATED PRESS

2:18 p.m. February 13, 2006

WASHINGTON – The government won't wait for bird flu to hit U.S. shores before granting liability protections to vaccine manufacturers and others that make products needed to battle a pandemic. Health and Human Services Secretary Mike Leavitt said Monday that the administration soon would enter into contracts for bird flu vaccine, rapid tests to detect the virus, and technology that would make available vaccine go farther.

“At some point in that process, we'll need to deal with the issue of liability,” he told reporters. In December, Congress gave Leavitt the authority to grant liability waivers if a public health emergency exists. Under the waivers, people injured by a vaccine against bird flu would have to prove willful misconduct to bring a claim for damages. Critics have said that such a high threshold would make it almost impossible for people injured by a drug to file a lawsuit. Leavitt said it's possible that vaccine manufacturers would want the extra protections before conducting clinical trials. “If you're a vaccine manufacturer, you're likely not going to want to move to that step unless you've got adequate liability protection.” he said.

Re: Merck drug generates pre-release controversy

Leavitt has already declared bird flu an epidemicThere was a news report from February stating that Leavitt expected to declare bird flu pandemic under the new law, but as far as I know he has not officially done so yet.Do you mean he has described it as an epidemic, so he will likely invoke the "pandemic countermeasure" provisions of the "Public Readiness and Emergency Preparedness Act". If Leavitt had already done so I thought we would have heard something about it.Anything specific that you heard or read?On May 20, 2006, at 11:04 PM, Kerbob wrote:

[Guest guest]

The level of misdeeds and corruption at the upper levels of our government and the interplay between those upper levels of government, industry and the investment community is the most repugant form of illegal insider trading activity you can possibly imagine. The Y2K birdflu scam is just the latest. Especially when you consider who benefits from this "pandemic".

The pawns in this chess game:

the soldiers in Iraq;

the kids who get poisoned by the vaccines and other agents;

first responders;

numerous others who are essentially honest and believe much of the philosophy which has made this nation great- and act on it.

The reason why the government is critical to the business/investment communities is because they can force you to participate in the business scam to the benefit of the corporate benefactors.

The problem we have is that we simply do not know what information is reliable and who is double-dealing us and because there has been a concentration of business/information activity into only a few hands, that information has to be perceived as unreliable. We have experienced the dishonesty firsthand. But it is rampant in numerous other places.

The question becomes how much information we are getting is even reliable and whether we can trust the traditional groups we rely on to provide that information. Most of that information is boobbait for various groups having traditional beliefs, relatively low critical thought processes or simply people who wish to believe that their government is an honest broker. It is not.

We get manipulated by fear to further a belief set. It is the worst pathology imaginable. It is only our fault to the extent that we let this BS go on.

None of our government agencies are believed to be honest brokers anymore. and they are incapable of providing the necessary oversight required to provide honest information.

The term "government approved" becomes laughable.

We see it on this website. We see it virtually everywhere.

That is what this society perceives. It is not just in the vaccine/thimerosal/autism debte, but it is palpable just about everywhere.

That is why noone trusts the present administration.

This translates into numerous problems for the CDC/others in trying to push the vaccines and avoid the tsunami of informed consent.

That is how this debate resolves itself, at least with respect to future vaccination issues.

They must resolve the past as well- the damage they created.

RERe: Merck drug generates pre-release controversy

In my conspiracy frame of mind , I imagine that all of these girls get the shot starting this fall at the same time the bird flu crosses into Alaska (CNN reports that the scientists are testing migratory birds), unlike what the article states (that girls have responsive immune systems), these girls will might actually have suppressed immune systems from the impending bird flu. Or the other scenario I see, is that these girls (like our autistic sons and daughters) may have a toxic overload from the new shot and become a new form of autism. The article here already states that they do not know the long term effects; therefore, once again, the medically establishment gets to experiment on children while they pocket the wealth. I sure would like to hear more from the doctors who have reservations about this new vaccine.

[Guest guest]

Right, this is the same report I was thinking of - strongly indicates

that Leavitt will invoke the " pandemic countermeasure " provision of the

statute, but he has not yet done so. Will happen when the clinical

trials are going to begin - Leavitt almost has to do this to fulfill

government contracts with the vaccine manufacturers.

On May 21, 2006, at 3:06 AM, Kerbob wrote:

> http://www.npr.org/templates/story/story.php?storyId=5068163

>  

> Under the law, manufacturers would receive the protection from

> lawsuits when the Secretary of Health and Human Services declares a

> particular disease as an " epidemic. " Already HHS Secretary Mike

> Leavitt has used the word epidemic in relation to AIDS, obesity,

> diabetes and chronic diseases in general, potentially broadening the

> legal protections to many drugs now in existence or under development.

>  

> http://www.signonsandiego.com/news/health/20060213-1418-birdflu-

> leavitt.html

>  

> By Freking

> ASSOCIATED PRESS

>

> 2:18 p.m. February 13, 2006

>

> WASHINGTON – The government won't wait for bird flu to hit U.S. shores

> before granting liability protections to vaccine manufacturers and

> others that make products needed to battle a pandemic.

>

> Health and Human Services Secretary Mike Leavitt said Monday that the

> administration soon would enter into contracts for bird flu vaccine,

> rapid tests to detect the virus, and technology that would make

> available vaccine go farther.

>

> “At some point in that process, we'll need to deal with the issue of

> liability,†he told reporters.

>

> In December, Congress gave Leavitt the authority to grant liability

> waivers if a public health emergency exists.

>

> Under the waivers, people injured by a vaccine against bird flu would

> have to prove willful misconduct to bring a claim for damages. Critics

> have said that such a high threshold would make it almost impossible

> for people injured by a drug to file a lawsuit.

>

> Leavitt said it's possible that vaccine manufacturers would want the

> extra protections before conducting clinical trials.

>

> “If you're a vaccine manufacturer, you're likely not going to want to

> move to that step unless you've got adequate liability protection.†he

> said.

>> Re: Merck drug generates pre-release controversy

>>

>>

>>> Leavitt has already declared bird flu an epidemic

>>

>>

>> There was a news report from February stating that Leavitt expected

>> to declare bird flu pandemic under the new law, but as far as I know

>> he has not officially done so yet.

>>

>> Do you mean he has described it as an epidemic, so he will likely

>> invoke the " pandemic countermeasure " provisions of the " Public

>> Readiness and Emergency Preparedness Act " . If Leavitt had already

>> done so I thought we would have heard something about it.

>>

>> Anything specific that you heard or read?

>>

>>

>> On May 20, 2006, at 11:04 PM, Kerbob wrote:

>>

>

>

>

[Guest guest]



From the sound of it basically it's a vaccine manufacturers' call. Leavitt abdicated right away.

Re: Merck drug generates pre-release controversy

Leavitt has already declared bird flu an epidemicThere was a news report from February stating that Leavitt expected to declare bird flu pandemic under the new law, but as far as I know he has not officially done so yet.Do you mean he has described it as an epidemic, so he will likely invoke the "pandemic countermeasure" provisions of the "Public Readiness and Emergency Preparedness Act". If Leavitt had already done so I thought we would have heard something about it.Anything specific that you heard or read?On May 20, 2006, at 11:04 PM, Kerbob wrote: